- Home
- NNOX vs GNFT Comparison
NNOX vs GNFT Comparison
Compare NNOX & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- GNFT
- Stock Information
- Founded
- NNOX 2011
- GNFT 1999
- Country
- NNOX Israel
- GNFT France
- Employees
- NNOX N/A
- GNFT N/A
- Industry
- NNOX Medical Electronics
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NNOX Health Care
- GNFT Health Care
- Exchange
- NNOX Nasdaq
- GNFT Nasdaq
- Market Cap
- NNOX 253.8M
- GNFT 216.7M
- IPO Year
- NNOX 2020
- GNFT 2019
- Fundamental
- Price
- NNOX $3.73
- GNFT $4.19
- Analyst Decision
- NNOX Strong Buy
- GNFT Strong Buy
- Analyst Count
- NNOX 2
- GNFT 2
- Target Price
- NNOX $8.50
- GNFT $10.00
- AVG Volume (30 Days)
- NNOX 1.3M
- GNFT 5.1K
- Earning Date
- NNOX 11-20-2025
- GNFT 09-22-2025
- Dividend Yield
- NNOX N/A
- GNFT N/A
- EPS Growth
- NNOX N/A
- GNFT N/A
- EPS
- NNOX N/A
- GNFT N/A
- Revenue
- NNOX $11,886,000.00
- GNFT $52,994,715.00
- Revenue This Year
- NNOX $20.50
- GNFT $3.14
- Revenue Next Year
- NNOX $64.10
- GNFT N/A
- P/E Ratio
- NNOX N/A
- GNFT N/A
- Revenue Growth
- NNOX 17.36
- GNFT N/A
- 52 Week Low
- NNOX $3.60
- GNFT $2.55
- 52 Week High
- NNOX $11.00
- GNFT $6.03
- Technical
- Relative Strength Index (RSI)
- NNOX 41.38
- GNFT 52.42
- Support Level
- NNOX $3.86
- GNFT $4.07
- Resistance Level
- NNOX $4.17
- GNFT $4.40
- Average True Range (ATR)
- NNOX 0.21
- GNFT 0.15
- MACD
- NNOX -0.04
- GNFT 0.01
- Stochastic Oscillator
- NNOX 3.85
- GNFT 54.19
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.